Fact CheckerSign in

NCT06206954Enrolling by invitation

Supporting Decisions on Lifestyle Change

Increasing Initiation of Evidence-based Weight Loss Treatment

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

This study will test the effects of a brief, individually tailored intervention aiming to increase initiation of comprehensive behavioral weight loss treatment on weight.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
864 (estimated)
First submitted
2 Jan 2024
Start date
24 Jan 2024
Primary completion date
30 Apr 2028
Lead sponsor
University of Florida
Diseases
Obesity
NCT number
NCT06206954

What you commit to

  • Study type: Interventional
  • Planned participants: 864
  • From 24 Jan 2024 to the primary completion date, 30 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Bariatric surgery in the past year or currently undergoing evaluation for bariatric surgery
  • Currently taking doctor-prescribed medication for weight loss

Other illness

  • Currently undergoing treatment for cancer
  • Inpatient psychiatric treatment in the past 6 months
  • Eating disorder in past 5 years
  • Congestive heart failure resulting in recent (past 6 months) hospitalization or contributing to difficulty breathing or difficulty doing daily activities.
  • Dementia diagnosis

Other

  • Currently enrolled in evidence-based comprehensive weight loss treatment
  • Pregnant or planning to become pregnant in the next 6 months
  • Currently breastfeeding (or pumping breastmilk) more than 3 times per day.
  • Had cardiovascular event in the past 60 days
  • Severe depression symptoms on PHQ-8 (total score ≥20)
  • Inability to stand on body weight scale independently
  • Impaired hearing
  • Unable to read content on websites without assistance

Who the study is looking for

  • Age 18 or older
  • Body Mass Index (BMI) ≥ 30 kg/m2 based on self-report body weight and height, or BMI ≥ 27-29.9 kg/m2 with a weight related comorbidity of hypertension, type 2 diabetes, pre-diabetes, dyslipidemia, or obstructive sleep apnea, gastroesophageal reflux disease, or coronary artery disease.
  • Self-report weight ≤ 375 lbs (the maximum weight that BodyTrace scales can accurately detect is 397 lbs, thus 375 lbs provides a buffer to allow detection of at least 20 lbs weight gain).
  • Has a desire to weigh less
  • Has valid email address in Electronic Health Record
  • Has an appointment scheduled with enrolled PCP about 21-28 days after electronic data pull
  • Speaks and reads English
  • Has either WiFi internet access at home or a phone or tablet with a data plan.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Florida
Coordinator of this site? Confirm its status
GainesvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.